Leerink maintains Outperform on OmniAb, keeps $12 target
Leerink Partners maintained its Outperform rating on OmniAb and kept a $12.00 price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.